Your browser doesn't support javascript.
loading
Non-binary gender, vulnerable populations and mental health during the COVID-19 pandemic: Data from the COVID-19 MEntal health inTernational for the general population (COMET-G) study.
Fountoulakis, Konstantinos N; Vrublevska, Jelena; Abraham, Seri; Adorjan, Kristina; Ahmed, Helal Uddin; Alarcón, Renato D; Arai, Kiyomi; Auwal, Sani Salihu; Berk, Michael; Bjedov, Sarah; Bobes, Julio; Bobes-Bascaran, Teresa; Bourgin-Duchesnay, Julie; Bredicean, Cristina Ana; Bukelskis, Laurynas; Burkadze, Akaki; Abud, Indira Indiana Cabrera; Castilla-Puentes, Ruby; Cetkovich, Marcelo; Colon-Rivera, Hector; Corral, Ricardo; Cortez-Vergara, Carla; Crepin, Piirika; De Berardis, Domenico; Delgado, Sergio Zamora; De Lucena, David; De Sousa, Avinash; Di Stefano, Ramona; Dodd, Seetal; Elek, Livia Priyanka; Elissa, Anna; Erdelyi-Hamza, Berta; Erzin, Gamze; Etchevers, Martin J; Falkai, Peter; Farcas, Adriana; Fedotov, Ilya; Filatova, Viktoriia; Fountoulakis, Nikolaos K; Frankova, Iryna; Franza, Francesco; Frias, Pedro; Galako, Tatiana; Garay, Cristian J; Garcia-Álvarez, Leticia; García-Portilla, Maria Paz; Gonda, Xenia; Gondek, Tomasz M; González, Daniela Morera; Gould, Hilary.
Afiliación
  • Fountoulakis KN; 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki Greece, Thessaloniki, Greece.
  • Vrublevska J; Riga Centre of Psychiatry and Addiction Disorders, Latvia. Electronic address: vrublevskaja@inbox.lv.
  • Abraham S; Pennine Care NHS Foundation Trust, United Kingdom; Manchester Metropolitan University, Manchester, United Kingdom; Core Psychiatry Training, Health Education England North West, United Kingdom. Electronic address: seri.abraham@nhs.net.
  • Adorjan K; Department of Psychiatry, Ludiwig-Maximilians-University, Munich, Germany. Electronic address: Kristina.Adorjan@med.uni-muenchen.de.
  • Ahmed HU; Child Adolescent and Family Psychiatry, National Institute of Mental Health, Dhaka, Bangladesh.
  • Alarcón RD; Section of Psychiatry and Mental Health, Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado, Lima, Peru; Department of Psychiatry and Psychology, Mayo Clinic School of Medicine, Rochester, MN, USA. Electronic address: renato.alarcon@upch.pe.
  • Arai K; School of Medicine and Health Science, Institute of Health Science Shinshu University, Matsumoto, Japan. Electronic address: k_arai@shinshu-u.ac.jp.
  • Auwal SS; Department of Psychiatry, Bayero University, Kano, Nigeria; Aminu Kano Teaching Hospital, Kano, Nigeria.
  • Berk M; IMPACT - the Institute for Mental and Physical Health and Clinical Translation, Deakin University, School of Medicine, Barwon Health, Geelong, Australia; Orygen The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Heal
  • Bjedov S; Department of Psychiatry and Psychological Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Bobes J; Psychiatry Area, Department of Medicine, University of Oviedo, Oviedo, Spain; Department of Psychiatry, Hospital Universitario Central de Asturias, Oviedo, Spain. Electronic address: bobes@uniovi.es.
  • Bobes-Bascaran T; Mental Health Center of La Corredoria, Oviedo, Spain; Department of Psychology, University of Oviedo, Oviedo, Spain. Electronic address: bobesmaria@uniovi.es.
  • Bourgin-Duchesnay J; Division of Child and Adolescent Psychiatry, Department of Psychiatry, Groupe Hospitalier Nord Essonne, Orsay, France.
  • Bredicean CA; Department of Neuroscience, Discipline of Psychiatry, "Victor Babes" University of Medicine and Pharmacy, Timisoara, Romania.
  • Bukelskis L; Clinic of Psychiatry, Institute of Clinical Medicine, Medical Faculty, Vilnius University, Vilnius, Lithuania.
  • Burkadze A; Mental Hub, Tbilisi, Georgia; NGO Healthcare Research and Quality Agency, Tbilisi, Georgia.
  • Abud IIC; Hospital San Juan de Dios Hospital, Guadalajara, Mexico.
  • Castilla-Puentes R; Janssen Research and Development, Johnson & Johnson, American Society of Hispanic Psychiatry and WARMI Women Mental Health, Cincinnati, OH, USA. Electronic address: rcastil4@its.jnj.com.
  • Cetkovich M; Institute of Translational and Cognitive Neuroscience (INCyT), INECO Foundation, Favaloro University, Buenos Aires, Argentina; National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina. Electronic address: mcetkovich@ineco.org.ar.
  • Colon-Rivera H; APM Board Certified in General Psychiatry and Neurology, Addiction Psychiatry, & Addiction Medicine, UPMC, DDAP, Philadelphia, USA.
  • Corral R; Department of Teaching and Research, Hospital Borda, Buenos Aires, Argentina; University of Buenos Aires, Buenos Aires, Argentina.
  • Cortez-Vergara C; Universidad Peruana Cayetano Heredia, Clínica AngloAmericana, Lima, Peru. Electronic address: carla.cortez.v@upch.pe.
  • Crepin P; Sanitaire and Social Union for Accompaniment and Prevention, Center of Ambulatory Psychiatry of Narbonne and Lezigan, Narbonne, France.
  • De Berardis D; Department of Mental Health, Psychiatric Service of Diagnosis and Treatment, Hospital "G. Mazzini", ASL Teramo, Teramo, Italy; School of Nursing, University of L'Aquila, Italy; Department of Neuroscience and Imaging, School of Psychiatry, University of Chieti, Chieti, Italy. Electronic address: dome
  • Delgado SZ; Child and Adolescent Psychiatry Department, Hospital Luis Calvo Mackenna, Santiago, Chile. Electronic address: szamora@calvomackenna.cl.
  • De Lucena D; Departamento de Fisiología e Farmacología, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil. Electronic address: alienista@ufc.br.
  • De Sousa A; Department of Psychiatry, Lokmanya Tilak Municipal Medical College, Mumbai, India; Desousa Foundation, Mumbai, India.
  • Di Stefano R; Department of Biotechnological and Applied Clinical Sciences, Section of Psychiatry, University of L'Aquila, L'Aquila, Italy.
  • Dodd S; IMPACT - the Institute for Mental and Physical Health and Clinical Translation, Deakin University, School of Medicine, Barwon Health, Geelong, Australia; Orygen The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Heal
  • Elek LP; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
  • Elissa A; Department of Psychiatry, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia.
  • Erdelyi-Hamza B; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
  • Erzin G; Psychiatry Department, Ankara Diskapi Training and Research Hospital, Ankara, Turkey; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Etchevers MJ; Faculty of Psychology, University of Buenos Aires (UBA), Buenos Aires, Argentina.
  • Falkai P; Department of Psychiatry, Ludiwig-Maximilians-University, Munich, Germany. Electronic address: Peter.Falkai@med.uni-muenchen.de.
  • Farcas A; Centre of Neuroscience, Queen's University, Kingston, Ontario, Canada. Electronic address: 6amf@queensu.ca.
  • Fedotov I; Department of Psychiatry and Narcology, Ryazan State Medical University n.a. academician I.P. Pavlov, Ryazan, Russia.
  • Filatova V; State Budgetary Institution of the Rostov Region "Psychoneurological Dispensary", Rostov-on-Don, Russia.
  • Fountoulakis NK; Faculty of Medicine, Medical University of Sofia, Bulgaria.
  • Frankova I; Medical Psychology, Psychosomatic Medicine and Psychotherapy Department, Bogomolets National Medical University, Kyiv, Ukraine.
  • Franza F; "Villa dei Pini" Psychiatric Rehabilitation Center, Avellino, Italy; Psychiatric Studies Centre, Provaglio d'Iseo, Italy.
  • Frias P; Hospital Magalhães Lemos, Porto, Portugal.
  • Galako T; Department of Psychiatry, Medical Psychology and Drug Abuse, Kyrgyz State Medical Academy, Bishkek, Kyrgyz Republic.
  • Garay CJ; Faculty of Psychology, University of Buenos Aires (UBA), Buenos Aires, Argentina. Electronic address: cristiangaray@psi.uba.ar.
  • Garcia-Álvarez L; Department of Psychology, University of Oviedo, Oviedo, Spain.
  • García-Portilla MP; Psychiatry Area, Department of Medicine, University of Oviedo, Oviedo, Spain; Mental Health Center of La Ería, Oviedo, Spain. Electronic address: albert@uniovi.es.
  • Gonda X; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
  • Gondek TM; Specialty Training Section, Polish Psychiatric Association, Wroclaw, Poland.
  • González DM; Instituto Nacional de Psiquiatría Ramón De la Fuente Muñiz, Mexico City, Mexico.
  • Gould H; Department of Psychiatry, University of California San Diego, San Diego, USA. Electronic address: hgould@health.ucsd.edu.
J Affect Disord ; 352: 536-551, 2024 May 01.
Article en En | MEDLINE | ID: mdl-38382816
ABSTRACT

BACKGROUND:

The COVID-19 pandemic has brought significant mental health challenges, particularly for vulnerable populations, including non-binary gender individuals. The COMET international study aimed to investigate specific risk factors for clinical depression or distress during the pandemic, also in these special populations.

METHODS:

Chi-square tests were used for initial screening to select only those variables which would show an initial significance. Risk Ratios (RR) were calculated, and a Multiple Backward Stepwise Linear Regression Analysis (MBSLRA) was followed with those variables given significant results at screening and with the presence of distress or depression or the lack of both of them.

RESULTS:

The most important risk factors for depression were female (RR = 1.59-5.49) and non-binary gender (RR = 1.56-7.41), unemployment (RR = 1.41-6.57), not working during lockdowns (RR = 1.43-5.79), bad general health (RR = 2.74-9.98), chronic somatic disorder (RR = 1.22-5.57), history of mental disorders (depression RR = 2.31-9.47; suicide attempt RR = 2.33-9.75; psychosis RR = 2.14-10.08; Bipolar disorder RR = 2.75-12.86), smoking status (RR = 1.15-5.31) and substance use (RR = 1.77-8.01). The risk factors for distress or depression that survived MBSLRA were younger age, being widowed, living alone, bad general health, being a carer, chronic somatic disorder, not working during lockdowns, being single, self-reported history of depression, bipolar disorder, self-harm, suicide attempts and of other mental disorders, smoking, alcohol, and substance use.

CONCLUSIONS:

Targeted preventive interventions are crucial to safeguard the mental health of vulnerable groups, emphasizing the importance of diverse samples in future research.

LIMITATIONS:

Online data collection may have resulted in the underrepresentation of certain population groups.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / COVID-19 Límite: Female / Humans / Male Idioma: En Revista: J Affect Disord Año: 2024 Tipo del documento: Article País de afiliación: Grecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trastornos Relacionados con Sustancias / COVID-19 Límite: Female / Humans / Male Idioma: En Revista: J Affect Disord Año: 2024 Tipo del documento: Article País de afiliación: Grecia